Mammography screening: Patient information leaflets do not affect willingness to participate

February 20, 2015

In Germany, the invitation to undergo mammography screening that is sent to all women between the ages of 50 and 69 is accompanied by an information leaflet explaining the advantages and disadvantages of screening. In this issue of Deutsches Ärzteblatt International (Dtsch Arztbl Int 2015; 112: 61-8), Elisabeth Gummersbach and colleagues report on a study in which they determined how well the prospective subjects understood the information presented and whether this information influenced their willingness to undergo screening. It was found that the leaflet itself made little or no difference to the women's willingness to participate. Rather, the most important factor in the decision whether to be screened was usually a doctor's personal recommendation.

From 2010 onward, mammography for the early detection of breast cancer has been recommended for all women in Germany aged 50 to 69. Screening nonetheless remains controversial. While it is true that women who undergo screening are less likely to die of breast cancer, they may also receive erroneous diagnoses and unnecessary treatments. Out of 1000 women who undergo mammography screening regularly for 10 years, 1 to 3 will survive who would otherwise have died of breast cancer, but 100 to 300 will have a false positive mammography finding that can cause considerable emotional distress. As many as 5 of these women may actually undergo unnecessary treatment for cancer. As the authors point out, the leaflets apparently had little or no effect on the women's decisions to undergo screening or not: only 3.6% said it played a role in their decision, while nearly 50% said their doctor's recommendation was a major factor. These findings imply that a leaflet alone does not enable women to make a well-informed decision about mammography screening, as required by current German law. The authors recommend that women who are candidates for mammography should have a personal discussion with an appropriate professional about this subject, in addition to being given suitable written information.
-end-
http://www.aerzteblatt.de/pdf.asp?id=167468

Deutsches Aerzteblatt International

Related Breast Cancer Articles from Brightsurf:

Oncotarget: IGF2 expression in breast cancer tumors and in breast cancer cells
The Oncotarget authors propose that methylation of DVDMR represents a novel epigenetic biomarker that determines the levels of IGF2 protein expression in breast cancer.

Breast cancer: AI predicts which pre-malignant breast lesions will progress to advanced cancer
New research at Case Western Reserve University in Cleveland, Ohio, could help better determine which patients diagnosed with the pre-malignant breast cancer commonly as stage 0 are likely to progress to invasive breast cancer and therefore might benefit from additional therapy over and above surgery alone.

Partial breast irradiation effective treatment option for low-risk breast cancer
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical trial involving researchers from The Ohio State University Comprehensive Cancer Center - Arthur G.

Breast screening linked to 60 per cent lower risk of breast cancer death in first 10 years
Women who take part in breast screening have a significantly greater benefit from treatments than those who are not screened, according to a study of more than 50,000 women.

More clues revealed in link between normal breast changes and invasive breast cancer
A research team, led by investigators from Georgetown Lombardi Comprehensive Cancer Center, details how a natural and dramatic process -- changes in mammary glands to accommodate breastfeeding -- uses a molecular process believed to contribute to survival of pre-malignant breast cells.

Breast tissue tumor suppressor PTEN: A potential Achilles heel for breast cancer cells
A highly collaborative team of researchers at the Medical University of South Carolina and Ohio State University report in Nature Communications that they have identified a novel pathway for connective tissue PTEN in breast cancer cell response to radiotherapy.

Computers equal radiologists in assessing breast density and associated breast cancer risk
Automated breast-density evaluation was just as accurate in predicting women's risk of breast cancer, found and not found by mammography, as subjective evaluation done by radiologists, in a study led by researchers at UC San Francisco and Mayo Clinic.

Blood test can effectively rule out breast cancer, regardless of breast density
A new study published in PLOS ONE demonstrates that Videssa® Breast, a multi-protein biomarker blood test for breast cancer, is unaffected by breast density and can reliably rule out breast cancer in women with both dense and non-dense breast tissue.

Study shows influence of surgeons on likelihood of removal of healthy breast after breast cancer dia
Attending surgeons can have a strong influence on whether a patient undergoes contralateral prophylactic mastectomy after a diagnosis of breast cancer, according to a study published by JAMA Surgery.

Young breast cancer patients undergoing breast conserving surgery see improved prognosis
A new analysis indicates that breast cancer prognoses have improved over time in young women treated with breast conserving surgery.

Read More: Breast Cancer News and Breast Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.